17th Annual Cardiometabolic Health Congress On-Demand

Hundreds of practitioners gathered in Boston in October 2022 for the annual conference from Cardiometabolic Health Congress (CMHC). In the past 17 years, this medical conference has grown to be the biggest and most-anticipated event in evidence-based education for the diagnosis, treatment, and management of cardiometabolic diseases and risk factors. The On-Demand program includes all recordings from the general sessions of the live meeting; CME Symposia are posted as separate activities within the CMHC Educational Platform.

Target Audience

The educational design of this activity addresses the needs of US-based healthcare professionals, including cardiologists, endocrinologists, lipidologists, primary care clinicians (PCPs), registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals involved in the management and treatment of cardiometabolic patients.

Learning Objectives

After completing this activity, the participant should be better able to:

Discuss the interrelationships among cardiometabolic risk factors and their impact on the development of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease.
Interpret the latest evidence and guidelines for the prevention, screening, and treatment of the complex patient with cardiometabolic risk or cardiometabolic disease.
Outline strategies aimed at timely screening and prevention of cardiometabolic disease, including assessment of risk factors and biomarkers, and lifestyle modifications.
Develop individualized treatment regimens for patients with cardiometabolic disease based on the efficacy and safety of current and new pharmacotherapies, patient comorbidities and preferences in order to optimize outcomes.
Summarize recent evidence for emerging therapies in order to stay current with the most recent updates in the cardiometabolic field.
Review the impacts of aging on cardiometabolic risk, as well as best practices for the prevention and treatment of cardiometabolic risk and disease in older adults.

Course summary

Available credit:

18.50 ABIM MOC and AMA PRA Category 1 Credit™
18.50 ACPE Pharmacy
18.50 AMA PRA Category 1 Credit™
18.50 ANCC
18.50 CDE
18.50 Participation

Course opens:

12/13/2022

Course expires:

12/13/2023

Rating:

CMHC Chairpersons

George L. Bakris, MD | Director, Am Heart Assoc. Comprehensive Hypertension Center, University of Chicago Medicine
Christie M. Ballantyne, MD | Professor of Medicine, Baylor College of Medicine
Robert H. Eckel, MD | Professor of Medicine, Emeritus, University of Colorado Anschutz Medical Campus
Anne L. Peters, MD | Director, Clinical Diabetes Program, Keck School of Medicine of USC

Senior Planning Committee

Deepak L. Bhatt, MD | Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center
Keith C. Ferdinand, MD, FACC, FAHA | Professor of Medicine, Tulane University School of Medicine
Pam R. Taub, MD, FACC | Professor of Medicine, UC San Diego

Faculty

Rajiv Agarwal, MD, MS | Professor of Medicine, Indiana University
Vanita R. Aroda, MD Director, Diabetes Clinical Research, Brigham and Women’s Hospital
Louis J. Aronne, MD, FACP, DABOM | Sanford I. Weill Professor of Metabolic Research & Medical Director, Comprehensive Weight Control Center, Weill Cornell Medicine
Michael J. Blaha, MD MPH | Director of Clinical Research, Johns Hopkins Ciccarone Center, Johns Hopkins
Brent Egan, MD | Vice-President Cardiovascular Health, American Medical Association
Alison B. Evert, MS, RDN, CDCES | Manager, Nutrition and Diabetes Programs, UW Medicine Primary Care
Kenneth R. Feingold, MD | Professor Emeritus, University of California San Francisco
Juan P. Frias, MD | Medical Director and Principal Investigator, Velocity Clinical Research
Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES | Certified Diabetes Care and Education Specialist, University of Chicago
Irl B. Hirsch, MD | Professor of Medicine, University of Washington
Jill A. Kanaley, PhD | Professor and interim Chair, Nutrition and Exercise Physiology, University of Missouri
Donald M. Lloyd-Jones, MD | Eileen M. Foell Professor of Heart Research Professor of Preventive Medicine, Medicine, and Pediatrics Chair, Department of Preventive Medicine Past President, American Heart Association , Northwestern University
Michelle Look, MD, FAAFP | Family Practice-Sports Medicine -Obesity Medicine Physician, San Diego Weight and Wellness
Marie E. McDonnell, MD | Chief of Diabetes Section and Director of the Diabetes Program, Brigham & Women's Hospital
Erin D. Michos, MD, MHS | Director of Women's Cardiovascular Health, Johns Hopkins University School of Medicine
Patrick M. Moriarty, MD | Director of Clinical Pharmacology, The University of Kansas Health System
Alanna A. Morris, MD, MSc | Associate Professor of Medicine, Emory University School of Medicine
Louis H. Philipson, MD, PhD, FACP | James C. Tyree Professor of Diabetes Research and CareDirector, Kovler Diabetes Center, The University of ChicagoDepartments of Medicine and PediatricsSection of Endocrinology, Diabetes and Metabolism
Ileana L. Pina, MD, MPH | Prof of Medicine, Thomas Jefferson University
Dena Rifkin, MD, MS | Professor of Medicine, UCSD; Associate Chief of Medicine, VA San Diego, UC San Diego/VA San Diego
Joseph Saseen, PharmD | Associate Dean for Clinical Affairs and Professor, University of Colorado Anschutz Medical Campus
Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS | Obesity Medicine Physician Scientist, Massachusetts General Hospital/ Harvard Medical School
Raymond R. Townsend, MD | Professor of Medicine, Hospital of the University of Pennsylvania
Dennis T. Villareal, MD | Professor of Medicine, Baylor College of Medicine
Jeff D. Williamson, MD, MHS | Professor, Internal Medicine & Epidemiology; Chief, Section on Gerontology and Geriatric Medicine, Atrium Health Wake Forest Baptist

Disclosure link:

Faculty Disclosures

ESTIMATED TIME TO COMPLETE ACTIVITY
18.5 hours

JOINT PROVIDERSHIP STATEMENT

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Cardiometabolic Health Congress (CMHC). PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING EDUCATION
PACE designates this enduring activity for a maximum of 18.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 18.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

NURSING CONTINUING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 18.5 contact hours.

Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.

PHARMACY CONTINUING EDUCATION
PACE designates this continuing education activity for 18.5 contact hour(s) (1.85 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number - JA4008073-9999-22-251-H01-P. Type of activity: Knowledge

DIETITIAN CONTINUING EDUCATION
This program offers 18.5 CPEUs for dietitians.

DISCLOSURES
Information on planner and faculty disclosures can be found here.

DISCLOSURE OF CONFLICT OF INTEREST
PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

METHOD OF PARTICIPATION & REQUEST FOR CREDIT
There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registration is complete, you will receive a confirmation email with an access code and link back to this course.

If you attended the 2022 annual meeting, please reach out to info@cardiometabolichealth.org and we will provide you with complimentary access code to this activity.

During the period December 13, 2022 through December 13, 2023, participants must read the learning objectives and faculty disclosures, study the educational activity, obtain a score of 75% or better on the post-test, and complete the evaluation. Upon completing, your certificate will be available for print. For questions about receiving certificates, please contact us at CMHC_Eval@cardiometabolichealth.org.

For additional information about the accreditation of this activity, please visit https://partnersed.com

For Pharmacists: Please complete the evaluation instructions above. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks.

Available Credit

18.50 ABIM MOC and AMA PRA Category 1 Credit™
18.50 ACPE Pharmacy
18.50 AMA PRA Category 1 Credit™
18.50 ANCC
18.50 CDE
18.50 Participation

Status

Price

Title

Locked

$0.00Included

17th Annual Cardiometabolic Health Congress On-Demand